Tempest Therapeutics appoints Nancy Freda-Smith to board, names her audit committee chair
TPST•Board appointment and committee role
Tempest Therapeutics appointed Nancy Freda-Smith to its board of directors.
- Freda-Smith will serve as chair of the board’s audit committee.
- She most recently served as chief audit and risk officer at Ralph Lauren.
- Earlier roles include managing director at Deloitte & Touche, advising Fortune 500 clients on SEC reporting, capital markets deals, U.S. GAAP and IFRS.
